Cleared Abbreviated

NuFACE Mini Plus (K201680) - FDA 510(k) Clearance

Class II Neurology device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K201680 · Carole Cole Company · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2021
Decision
242d
Days
Class 2
Risk

K201680 is an FDA 510(k) clearance for the NuFACE Mini Plus. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by Carole Cole Company (Vista, US). The FDA issued a Cleared decision on February 19, 2021 after a review of 242 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Carole Cole Company devices

Submission Details

510(k) Number K201680 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 22, 2020
Decision Date February 19, 2021
Days to Decision 242 days
Submission Type Abbreviated
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
94d slower than avg
Panel avg: 148d · This submission: 242d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes

All 50
Devices cleared under the same product code (NFO) and FDA review panel - the closest regulatory comparables to K201680.
ZIIP+ Device
K212342 · Ziip, Inc. · Sep 2021
Avazzia OTC TENS for aesthetics, model BEST-AV1™: EZZI-LIFT™ Device
K191951 · Avazzia, Inc. · Apr 2021
Trinity ELE Plus and Trinity ELE Plus Pro
K201906 · Carol Cole Company Dba Nuface · Feb 2021
NuFace Trinity Plus Device
K201782 · Carol Cole Company Dba Nuface · Jan 2021
Tua Face Fitness / Tua Trend Face
K192077 · Vupiesse S.R.L · Sep 2020
BEAR and BEAR mini
K200803 · Foreo, Inc. · Jul 2020